Global Export Reach Bio Farma exports to numerous countries and serves domestic demand, presenting opportunities for long term vaccine supply contracts with government programs and international buyers through its state owned manufacturing base and public tender access.

Strategic Partnerships Existing collaborations with UNICEF, Gates Foundation, and Serum Institute open paths for co development, licensing, and contract manufacturing of vaccines such as nOPV2 and Tdap, including potential technology transfer to expand regional capacity.

Pipeline Growth Active vaccine development pipeline including niche and next generation vaccines offers opportunities to secure early supply agreements, capacity planning, and integration with customers seeking upgraded immunization solutions.

Regional Leadership Bio Farma's leadership in the DCVMN and regional event hosting position can help accelerate market entry in Southeast Asia and streamline adoption of new vaccines across neighboring countries and programs.

Financial Readiness The company’s funding profile supports scale up; explore co investment, manufacturing capacity expansion, and financing options for long term procurement deals and technology upgrades to meet growing demand.